- JPMorgan Chase (JPM +2.2%) is set to collect the largest individual fee to a bank for selling a company — $123M for advising Allergan (AGN +0.9%) on its planned $63B sale to AbbVie, the Financial Times reports, citing data from Dealogic.
- The details of the fee arrangement were disclosed this week by Allergan in the proxy statement for a shareholder vote on the transaction.
- Assuming the purchase is completed, JPMorgan’s fee will eclipse the $120M paid to Morgan Stanley for advising Monsanto on its $66B sale to Germany’s Bayer, according to Dealogic’s data.
Date: August 19, 2019
Source: Flipboard
